In addition, we will further explore whether glucagon-like peptide-1 receptor agonist(GLP-1RA), a widely used drug for T2DM, can affect the progression of CRC by meditating the expression of BMP4 [25]. The gene discussed is BMP4; the disease is colorectal carcinoma.